MetLife MSCI EAFE Index Portfolio OCSE:NOVO B Holdings History
MetLife MSCI EAFE Index Portfolio's Novo Nordisk AS Holding Summary
As of 2025-03-31, Brighthouse Funds Trust II held 259,870.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr17.99 Mil. This investment constitutes 1.29% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.01% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2019Q3. And since then MetLife MSCI EAFE Index Portfolio has made 2 purchases of OCSE:NOVO B, at an average price of kr328.46, for a total of 362,137.00 shares. In addition, there have been 14 sales at an average price of kr472.17 for 102,267.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, MetLife MSCI EAFE Index Portfolio's estimated gain on his OCSE:NOVO B holdings is kr46.62 Mil, reflecting a 39.19% gain to date.
MetLife MSCI EAFE Index Portfolio OCSE:NOVO B (kr451.30) Holding Chart
MetLife MSCI EAFE Index Portfolio OCSE:NOVO B (kr451.30) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
